CSN Login
Members Online: 19

CFI-400945 ("sharpshooter" drug)

Alexandra's picture
Posts: 1301
Joined: Jul 2012

The drug, known for now as CFI-400945, is a new class of cancer agent that targets an PLK4 enzyme involved in some malignancies, among them some types of breast cancer and ovarian, colorectal, pancreatic and prostate cancers.

Phase 1 trial is to start in September.



2timothy1 7's picture
2timothy1 7
Posts: 345
Joined: Jan 2012

Love the pic. Too cute! Thanks for researching and posting! We never know when one o these clinica trials will work for us:).

poopergirl14052's picture
Posts: 1185
Joined: Nov 2010

2013-06-24@finding good info. Thank you..nothing  can hide from you!   You are soooo cute...vVal 

Subscribe with RSS
About Cancer Society

The content on this site is for informational purposes only. It is not a substitute for professional medical advice. Do not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition. Use of this online service is subject to the disclaimer and the terms and conditions.

Copyright 2000-2015 © Cancer Survivors Network